醫師介紹
醫師學術論文
Paper
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | 黃裕鍇(Huang, Yu-Kai)、鄭維中(Cheng, Wei-Chung)、郭婷婷、楊顓丞(Juan-Cheng Yang)、吳永昌(Yang-Chang Wu)、吳恒祥(Wu, Heng-Hsiung)、羅佳茜(Chia-Chien Lo)、謝知穎(Chih-Ying Hsieh)、黃思澄(Sze-Ching Wong)、陸志豪(Chih-Hao Lu)、(Wan-Ling Wu)、劉士任(Shih-Jen Liu)、李易撰(Li, Yi-Chuan)、林精湛(Ching-Chan Lin)、沈家寧(Chia-Ning Shen)、洪明奇(Mien-Chie Hung)、林肇堂(Jaw-Town Lin)、葉俊杰(Yeh, Chun-Chieh)*、佘玉萍(Yuh-Pyng Sher)*,Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy,Nature Cancer,2023 Dec,(): | 2023 . 12 |
2 | 石輝弘(Daniel Winardi)、(Chieh-Hsin Wu)、(Jen-Huai Chiang)、陳永祥(Chen, Yung-Hsiang)、謝慶良(Ching-Liang Hsieh)、楊顓丞(Juan-Cheng Yang)*、吳永昌(Yang-Chang Wu)*,The Use of San-Huang-Xie-Xin-Tang Reduces the Mortality Rate among Breast Cancer Patients,Cancers,2023 Feb,15(4):1213 | 2023 . 02 |
3 | 余盈君、(Azaj Ahmad)、賴學洲(Hsueh-Chou Lai)、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang)、張維君(Wei-Chun Chang)、陳璐敏(Lu-Min Chen)、沈延盛*、馬文隆(Wen-Lung Ma)*,Review of the Endocrine Organ–Like Tumor Hypothesis of Cancer Cachexia in Pancreatic Ductal Adenocarcinoma,Frontiers in Oncology,2022 Nov,(): | 2022 . 11 |
4 | 馬文隆(Wen-Lung Ma)、張寧、余盈君、蘇鈺婷、陳冠宇、鄭維中、吳永昌(Yang-Chang Wu)、(Ching-CHia Li)、張維君(Wei-Chun Chang)*、楊顓丞(Juan-Cheng Yang)*,Ursolic acid silences CYP19A1/Aromatase to suppress gastric cancer growth,Cancer Medicine,2022 May,11():2824-2835 | 2022 . 05 |
5 | 石輝弘(DANIEL WINARDI)、朱珮儀、陳冠宇(Guan-Yu Chen)、(Ke Wang)、徐瑋佑、謝慶良(Ching-Liang Hsieh)、陳永祥(Chen, Yung-Hsiang)、吳永昌(Yang-Chang Wu)*、楊顓丞(Juan-Cheng Yang)*,Novel Aurora A Kinase Inhibitor Fangchinoline Enhances Cisplatin–DNA Adducts and Cisplatin Therapeutic Efficacy in OVCAR-3 Ovarian Cancer Cells-Derived Xenograft Model,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2022 Feb,23(3):1868 | 2022 . 02 |
6 | 陳冠宇(Guan-Yu Chen)、潘奕澄、(Tung-Ying Wu)、(Tsung-You Yao)、王韋然(Wang, Wei-Jan)、(Wan-Jou Shen)、(Azaj Ahmed)、(Shu-Ting Chan)、湯智昕(Chih-Hsin Tang)、黃偉謙(Huang, Wei-Chien)、洪明奇(Mien-Chie Hung)、楊顓丞(Juan-Cheng Yang)*、吳永昌(Yang-Chang Wu)*,Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay,Journal of Traditional and Complementary Medicine,2022 Jan,12(1):73-89 | 2022 . 01 |
7 | (Fen-Lan Wu)、朱珮儀、陳冠宇(Guan-Yu Chen)、(Ke Wang)、徐瑋佑、(Azaj Ahmed)、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、吳永昌(Yang-Chang Wu)*、楊顓丞(Juan-Cheng Yang)*,Natural Anthraquinone Compound Emodin as a Novel Inhibitor of Aurora A kinase: A pilot study,Chemical Biology & Drug Design,2022 Jan,99(1):126-135 | 2022 . 01 |
8 | 黃介良(Chieh-Liang Huang)、江耀璋、張維君(Wei-Chun Chang)、蘇鈺婷(Su, Yu-Ting)、楊顓丞(Juan-Cheng Yang)、鄭維中(Cheng, Wei-Chung)、藍先元(Hsien-Yuan Lane)、何英剛、馬文隆(Wen-Lung Ma)*,Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment,Frontiers in Endocrinology,2021 Aug,12(): | 2021 . 08 |
9 | 林文仁(Lin, Wun-Ren)、沈培鈞、劉修誠、卓奕君、徐敏恭、林依真(Lin, I-Chen)、(Chen FH)、楊顓丞(Juan-Cheng Yang)、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)*,LipidSig: a web-based tool for lipidomic data analysis,NUCLEIC ACIDS RESEARCH,2021 Jul,49(w1):W336-W345 | 2021 . 07 |
10 | (Yan-Cheng Liou)、林晏安(Lin, Yen-An)、王可(Ke Wang)、楊顓丞(Juan-Cheng Yang)、張永俊(Jang, Yeong-Jiunn)*、(Wenwei Lin)、吳永昌(Yang-Chang Wu)*,Synthesis of Novel Spiro-Tetrahydroqunioline Derivatives and Evaluation of Their Pharmacological Effects on Wound Healing,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2021 Jun,22(12):6251 | 2021 . 06 |
11 | 林晏安(Lin, Yen-An)、朱珮儀、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、(Shu-Ting Chan)、楊顓丞(Juan-Cheng Yang)*、吳永昌(Yang-Chang Wu)*,Enzyme-Digested Peptides Derived from Lates calcarifer Enhance Wound Healing after Surgical Incision in a Murine Model,Marine Drugs,2021 Mar,19(3):154 | 2021 . 03 |
12 | 戴昀皓(Dai,Yun-Hao)、陳冠宇(Guan-Yu Chen)、湯智昕(Chih-Hsin Tang)、黃偉謙(Wei-Chien Huang)、楊顓丞(Juan-Cheng Yang)*、吳永昌(Yang-Chang Wu)*,Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer,IN VIVO,2021 Mar,35(2):761-777 | 2021 . 03 |
13 | (Ke Wang)、楊顓丞(Juan-Cheng Yang)、張永俊(Jang, Yeong-Jiunn)、陳冠宇(Guan-Yu Chen)、(Ya-Jing Zhang)、戴昀皓(Dai,Yun-Hao)、(Da-Yong Zhang)*、吳永昌(Yang-Chang Wu)*,19-(Benzyloxy)-19-oxojolkinolide B (19-BJB), an ent-abietane diterpene diepoxide, inhibits the growth of bladder cancer T24 cells through DNA damage,PLoS One,2021 Mar,16(3):e0248468 | 2021 . 03 |
14 | Lumin Chen、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang)、王筱晴、蘇鈺婷、(Azaj Ahmed)、洪耀欽(Yao-Ching Hung)、張維君(Wei-Chun Chang)*,Targeting Lipid Droplet Lysophosphatidylcholine for Cisplatin Chemotherapy,JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2020 Jul,24(13):7187-7200 | 2020 . 07 |
15 | 范紀鎮(Chi-Chen Fan)、蔡昇達(Sheng-Ta Tsai)、林振源(Lin, Chen-Yuan)、張玲菊(Ling-Chu Chang)、楊顓丞(Juan-Cheng Yang)、陳冠宇(Guan-Yu Chen)、佘玉萍(Yuh-Pyng Sher)、王紹椿(Shao-Chun Wang)、蕭宏昇(Michael Hsiao)*、張為超(Wei-Chao Chang)*,EFHD2 Contributes to Non-Small Cell Lung Cancer Cisplatin Resistance by the Activation of NOX4-ROS-ABCC1 Axis,Redox Biology,2020 Jul,34():101571 | 2020 . 07 |
16 | 張維君(Wei-Chun Chang)、王筱晴、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang)、鍾瑋敏(Wei-Min Chung)、(Yen-Pin Ho)、(Lumin Chen)、洪耀欽(Yao-Ching Hung)、馬文隆(Wen-Lung Ma)*,LDLR-Mediated Lipidome-Transcriptome Reprogramming in Cisplatin Insensitivity,ENDOCRINE-RELATED CANCER,2020 Feb,(): | 2020 . 02 |
17 | 楊顓丞(Juan-Cheng Yang)、張寧(Ning Chang)、吳登強(Deng-Chyang Wu)、鄭維中(Wei-Chung Cheng)、鍾瑋敏(Wei-Min Chung)、張維君(Wei-Chun Chang)、雷馥如(Fu-Ju Lei)、劉忠榮(Chung-Jung Liu)、吳宜珍(I-Chen Wu)、賴學洲(Hsueh-Chou Lai)*、馬文隆(Wen-Lung Ma)*,Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer,JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2019 Sep,(): | 2019 . 09 |
18 | 李家琳(Chia-Lin Lee)、廖國宸(Liao, Kuo-Chen)、(Chien-Chih Chen)、(Yen-An Lin)、吳東穎(Tung-Ying Wu)、(Yun-Lian Jhan)、陳朝榮(Chao-Jung Chen)、楊顓丞(Juan-Cheng Yang)*、吳永昌(Yang-Chang Wu)*,Characterization of secondary metabolites from the rhizome of Cynara scolymus and their antioxidant properties,NATURAL PRODUCT RESEARCH,2019 Jul,(): | 2019 . 07 |
19 | (Ching-Ming Chien)、楊顓丞、(Pin-Hsuan Wu)、(Chang-Yi Wu)、陳冠宇(Guan-Yu Chen)、吳永昌(Wu, Yang-Chang)、Chon-Kit Cho、(Chih-Hua Tseng)、(Yeh-Long Chen)*、(Li-Fang Wang)*、(Chien-Chih Chiu)*,Phytochemical Naphtho[1,2-b] furan-4,5-dione Induced Topoisomerase II-mediated DNA Damage Response in Human Non-small-Cell Lung Cancer,PHYTOMEDICINE,2019 Feb,54():109-119 | 2019 . 02 |
20 | (Kuan-Ying Lai)、(Hao-Chun Hu)、江秀梅(Chiang, Hsiu-Mei)、(Yi-Jung Liu)、楊顓丞(Juan-Cheng Yang)、(Yen-An Lin)、陳朝榮(Chao-Jung Chen)、張永勳(Yuan-Shiun Chang)、李家琳(Chia-Lin Lee)*,New diterpenes leojaponins G–L from Leonurus japonicas,Fitoterapia,2018 Aug,130():125-133 | 2018 . 08 |
21 | (Man-Gang Lee)、(Yi-Chang Liu)、(Yi-Chang Liu)、(Mohamed El-Shazly)、(Kuei-Hung Lai)、(Shou-Ping Shih)、(Seng-Chung Ke)、(Ming-Chang Hong)、(Ying-Chi Du)、楊顓丞、宋秉鈞(Sung, Ping-Jyun)、(Zhi-Hong Wen)*、(Mei-Chin Lu)*,Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90,Marine Drugs,2018 Jun,16(6):204 | 2018 . 06 |
22 | (Fu-Ju Lei)、(Bi-Hua Cheng)、(Pei-Yin Liao)、(Hsiao-Ching Wang)、張維君(Chang, Wei-Chun)、賴學洲(Lai, Hsueh-Chou)、楊顓丞、吳永昌(Yang-Chang Wu)、(Li-Jing Ju)*、馬文隆(Ma, Wen-Lung)*,Survival Benefit of Sphingosin-1-Phosphate and Receptors Expressions in Breast Cancer Patients,Cancer Medicine,2018 May,():1-10 | 2018 . 05 |
23 | (Ming-Chang Lee)、(Shih-Ting Tseng)、楊顓丞、(Tung-Ju Hsieh)、(Shang-ChuenWu)、(Shu-Min Kuan)、(Ming-Jen Chen)、(Ming-Chiu Chang)、(Chun-Chiu Wang)、(Hsiu-Lin Chen)、(Guor-Cheng Fang)、(Winn-Jung Huang)、(Tzu-Ping Ko)*、陳曄(Chen,Yeh)*,Expression, Purification, Crystallization, and X-ray Structural Analysis of CRISPR-Associated Protein Cas6 from Methanocaldococcus jannaschii,Crystals,2017 Nov,7(11):344 | 2017 . 11 |
24 | (Jia-Chen Tung)、黃偉謙(Huang, Wei-Chien)、楊顓丞、陳冠宇(Guan-Yu Chen)、范紀鎮(Chi-Chen Fan)、簡毓娟(Chuan , Chien-Yu)、林佩姍、龍世俊(Shih-Chun Candice Lung)*、張為超(Chang, Wei-Chao)*,Auramine O, an incense smoke ingredient, promotes lung cancer malignancy,ENVIRONMENTAL TOXICOLOGY,2017 Nov,32(11):2379-2391 | 2017 . 11 |
25 | 陳毓昕(Yu-Hsin Chen)、陳武福(Wu-Fu Chen)、楊顓丞、呂美津(Mei-Chin Lu)、郭傑民(Jimmy Kuo)、蘇瑞欣(Jui-Hsin Su)、翁慶豐(Ching-Feng Weng)、吳永昌(Yang-Chang Wu)*、宋秉鈞(Ping-Jyun Sung)*,Pseudoalteromone C: a novel ubichromenol derivative from bacterium Pseudoalteromonas sp. CGH2XX isolated from the cultured-type octocoral Lobophytum crassum,Natural Product Communications,2017 Oct,12(10):1615-1617 | 2017 . 10 |
26 | (Yu-Hsin Chen)、楊顓丞、(Mei-Chin Lu)、(Ching-Feng Weng)、(Yin-Di Su)、(Jimmy Kuo)、(Yang-Chang Wu)*、宋秉鈞(Ping-Jyun Sung)*,Bafilomycins N and O, novel cytotoxic bafilomycin analogues produced by Streptomyces sp. GIC10-1 isolated from marine sponge Theonella sp.,TETRAHEDRON,2017 Aug,73(2017):5170-5175 | 2017 . 08 |
27 | 李家琳(Chia-Lin Lee)、楊顓丞、(Chieh-Yu Peng)、吳永昌(Yang-Chang Wu)*,Saponins from Solanum torvum and S. macaonense with Their Cytotoxic and Anti-allergic Effects,Natural Product Communications,2017 ,(): | 2017 . |
28 | (Kuei-Hung Lai)、(Mei-Chin Lu)、(Ying-Chi Du)、(Mohamed El-Shazly)、吳東穎(Tung-Ying Wu)、(Yu-Ming Hsu)、(Astrid Henz)、楊顓丞、(Anders Backlund)*、(Fang-Rong Chang)*、吳永昌(Yang-Chang Wu)*,Cytotoxic Lanostanoids from Poria cocos,JOURNAL OF NATURAL PRODUCTS,2016 Nov,79(11):2805-2813 | 2016 . 11 |
29 | (Kuei-Hung Lai)、(Yi-Chang Liu)、(Jui-Hsin Su)、(Mohamed El-Shazly)、(Chih-Fung Wu)、(Ying-Chi Du)、(Yu-Ming Hsu)、楊顓丞、(Ming-Kai Weng)、(Chia-Hua Chou)、陳冠宇(Guan-Yu Chen)、(Yu-Cheng Chen)、(Mei-Chin Lu)*,Antileukemic Scalarane Sesterterpenoids and Meroditerpenoid from Carteriospongia (Phyllospongia) sp., Induce Apoptosis via Dual Inhibitory Effects on Topoisomerase II and Hsp90,Scientific Reports,2016 Oct,6():36170 | 2016 . 10 |
30 | (Ke Wang)、吳永昌(Yang-Chang Wu)、楊顓丞、(Meng-Han Zhang)、(Mohamed El-Shazly)、(Da-Yong Zhang)、(Xiao-Ming Wu)*,Synthesis of Novel 3,19-Dihydroxyjolkinolides and Related Derivatives Starting from Andrographolide,SYNTHESIS-STUTTGART,2016 Jul,48(14):2245-2254 | 2016 . 07 |
31 | (Ching-Chia Li)、楊顓丞、(Mei-Chin Lu)、李家琳(Chia-Lin Lee)、(Chieh-Yu Peng)、(Wei-Yu Hsu)、(Yun-Hao Dai)、(Fang-Rong Chang)、(Da-Yong Zhang)、(Wen-Jeng Wu)*、吳永昌(Yang-Chang Wu)*,ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer,Oncotarget,2016 Jan,7(2):1947-1959 | 2016 . 01 |
32 | (Shou-Ping Shih)、(Man-Gang Lee)、(Mohamed El-Shazly)、(Yung-Shun Juan)、(Zhi-Hong Wen)、(Ying-Chi Du)、(Jui-Hsin Su)、(Ping-Jyun Sung)、(Yu-Cheng Chen)、楊顓丞、吳永昌(Yang-Chang Wu)*、(Mei-Chin Lu)*,Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities,Marine Drugs,2015 May,13(5):3132-3153 | 2015 . 05 |
33 | 李家琳(Chia-Lin Lee)*、(Ming-Hon Yen)、(Tsong-Long Hwang)、楊顓丞、彭婕妤(Chieh-Yu Peng)、陳朝榮(Chao-Jung Chen)、(Wen-Yi Chang)、吳永昌(Yang-Chang Wu),Anti-inflammatory and cytotoxic components from Dichrocephala integrifolia,Phytochemistry Letters,2015 May,12():237-242 | 2015 . 05 |
34 | 李家琳(Chia-Lin Lee)、(Tsong-Long Hwang)、楊顓丞、(Hao-Ting Cheng)、何宛融、(Chiao-Ting Yen)、郭昭麟(Kuo Chao-Lin)、陳朝榮(Chao-Jung Chen)、(Wen-Yi Chang)、吳永昌(Yang-Chang Wu)*,Anti-inflammatory spirostanol and furostanol saponins from Solanum macaonense,JOURNAL OF NATURAL PRODUCTS,2014 Jul,77(-):1770-1783 | 2014 . 07 |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | Taiwan Database of Extracts and Compounds (TDEC),ethnopharmacology2022,中國醫藥大學,2022.05.28~2022.05.31, | 2022 . 05 |
專書
暫無資料研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 個別型,NSTC 112-2320-B-039-060,李經家、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang),科技部,GSTO1調控脂質代謝體重編作為一種尿路上皮癌新的生長與抗藥性機制(3/3),2023.8.1~2024.7.31 | 2023 . 08 |
2 | 個別型,NSTC 112-2622-B-039-006,楊顓丞(Juan-Cheng Yang),科技部,ADAM9 抑制劑作為新穎抗胰臟癌藥物,2023.7.1~2024.6.30 | 2023 . 07 |
3 | 個別型,MOST 111-2320-B-039-058,李經家、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang),科技部,GSTO1調控脂質代謝體重編作為一種尿路上皮癌新的生長與抗藥性機制(2/3),2022.8.1~2023.7.31 | 2022 . 08 |
4 | 個別型,MOST 111-2320-B-039-059,鄭竣亦、周秉松、鄭維中(Cheng, Wei-Chung)、馬文隆(Wen-Lung Ma)、蔡銘駿(Ming-Jun Tsai)、楊顓丞(Juan-Cheng Yang),科技部,透過天然產物調節脂質和氨基酸代謝用於減輕阿茲海默症(3/3),2022.8.1~2023.7.31 | 2022 . 08 |
5 | 產學合作,11042631,,健茂生物科技股份有限公司,探討專利發酵技術改變扁實檸檬(臺灣香檬)植化素與次代謝物對於疾病動物模式血脂肪、血糖、體脂肪、肝功能等代謝功能異常之動物實驗研究,2021.9.10~2023.9.9 | 2021 . 09 |
6 | 個別型,MOST 110-2320-B-039-069,鄭竣亦、周秉松、鄭維中(Cheng, Wei-Chung)、馬文隆(Wen-Lung Ma)、蔡銘駿(Ming-Jun Tsai)、楊顓丞(Juan-Cheng Yang),科技部,透過天然產物調節脂質和氨基酸代謝用於減輕阿茲海默症(2/3),2021.8.1~2022.7.31 | 2021 . 08 |
7 | 個別型,MOST 110-2320-B-039-027,李經家、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang),科技部,GSTO1調控脂質代謝體重編作為一種尿路上皮癌新的生長與抗藥性機制(1/3),2021.8.1~2022.7.31 | 2021 . 08 |
8 | 個別型,DMR-111-019,,附醫院內計畫,探討芳香化酶影響胃癌發展之分子機制,並且開發新天然芳香化酶抑制劑,2021.8.1~2022.7.31 | 2021 . 08 |
9 | 個別型,CMU109-MF-15,,本校(含附醫),以GSTO1做為藥物標靶對抗鉑類藥物抗藥性策略,2020.9.8~2021.7.31 | 2020 . 09 |
10 | 個別型,MOST 109-2320-B-039-028,鄭竣亦、周秉松、鄭維中(Cheng, Wei-Chung)、馬文隆(Wen-Lung Ma)、蔡銘駿(Ming-Jun Tsai)、楊顓丞(Juan-Cheng Yang),科技部,透過天然產物調節脂質和氨基酸代謝用於減輕阿茲海默症(1/3),2020.8.1~2021.7.31 | 2020 . 08 |
11 | 整合型(召集人、總主持人),MOST 109-2327-B-039-002,鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang)、陳怡文(Yi-Wen Chen)、陳韻晶、李香君,科技部,以極低密度脂蛋白暨其受體為標靶之癌症新療法(1/3),2020.8.1~2021.7.31 | 2020 . 08 |
12 | 個別型,MOST 107-2320-B-039-017-MY3,,科技部,開發天然藥物衍生物為鉑類藥物輔助治療藥物用於侵犯型膀胱癌,2020.8.1~2021.7.31 | 2020 . 08 |
13 | 個別型,MOST 109-2320-B-039-006,楊顓丞(Juan-Cheng Yang),科技部,開發以芳香酶為標靶之新一代胃癌治療藥物,2020.8.1~2021.7.31 | 2020 . 08 |
14 | 個別型,CMU108-MF-22,,本校(含附醫),開發輔助鉑類藥物之天然藥物衍生物用於治療侵犯型膀胱癌,2019.9.9~2020.7.31 | 2019 . 09 |
15 | 個別型,MOST 107-2320-B-039-017-MY3,,科技部,開發天然藥物衍生物為鉑類藥物輔助治療藥物用於侵犯型膀胱癌,2019.8.1~2020.7.31 | 2019 . 08 |
16 | 個別型,MOST 108-2320-B-039-062-,楊顓丞(Juan-Cheng Yang),科技部,開發中草藥金銀花活性成分用於非肌肉侵犯型膀胱癌之輔助治療(3/3),2019.8.1~2020.7.31 | 2019 . 08 |
17 | 產學合作,107426CK,,財團法人工業技術研究院,白舞菇天然物活性評估試驗,2019.7.5~2019.12.31 | 2019 . 07 |
18 | 產學合作,107426CJ,吳永昌(Yang-Chang Wu)、楊顓丞(Juan-Cheng Yang),,白舞菇所含天然物化學萃取純化實驗,2019.6.21~2019.12.31 | 2019 . 06 |
19 | 個別型,MOST 107-2320-B-039-017-MY3,,科技部,開發天然藥物衍生物為鉑類藥物輔助治療藥物用於侵犯型膀胱癌,2018.8.1~2019.7.31 | 2018 . 08 |
20 | 產學合作,10642611,,景岳生物科技股份有限公司,具皮膚功效之益生菌有效成份分離純化,2017.8.1~2018.12.31 | 2017 . 08 |
21 | 個別型,MOST 106-2320-B-039-008-,吳永昌(Yang-Chang Wu)、馬文隆(Wen-Lung Ma)、張瑞仁(Jui-Jen Chang),科技部,開發天然藥物Casein Kinase II 蛋白抑制劑用於雌激素受體陽性之乳癌治療,2017.8.1~2018.7.31 | 2017 . 08 |
22 | 產學合作,10542675,,健茂生物科技股份有限公司,蔬果酵素檢測暨產品開發合作計畫,2017.1.1~2017.12.31 | 2017 . 01 |
23 | 個別型,MOST 105-2320-B-039-061-,馬文隆(Wen-Lung Ma),科技部,以中藥二萜類成分設計合成雌激素受體拮抗劑與PI3K抑制劑用於乳癌治療,2016.8.1~2017.7.31 | 2016 . 08 |
專利技術
專利/Patent (專利名稱,專利類別,專利國別,專利號碼,專利期間) |
日期 | |
1 | ADAM9抑制劑作為免疫調節劑之用途,發明專利,台灣,I735210,2021.8.1~2040.4.22 | 2021 . 08 |
2 | 用於抑制ADAM9活性之化合物、其醫藥組合物及其用途,發明專利,台灣,I695000,2020.6.1~2038.10.28 | 2020 . 06 |
3 | 包含ADAM9抑制剂化合物的组合物,發明專利,中國大陸,ZL 2018 8 0070735.8,2018.10.29~2038.10.28 | 2018 . 10 |
4 | 中草藥組合物製備抑制腫瘤細胞轉移之藥物之用途,發明專利,台灣,I635867,2018.9.21~2036.10.6 | 2018 . 09 |
5 | COMPOUND FOR INHIBITING ACTIVITY OF GLUTATHIONE S-TRANSFERASE OMEGA 1 AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUND,發明專利,歐洲,3081562,2018.2.28~2033.12.9 | 2018 . 02 |
6 | 用於抑制谷胱甘肽S-轉移酶 omega 1活性之化合物及其製備方法,發明專利,台灣,I 503315,2015.10.11~2033.2.6 | 2015 . 10 |
7 | 用於抑制谷胱甘肽S-轉移酶 omega 1活性之化合物及其製備方法,發明專利,日本,5778301,2015.9.16~2034.1.22 | 2015 . 09 |
8 | 用於抑制谷胱甘肽S-轉移酶 omega 1活性的化合物及其製備方法、和包含該化合物的醫藥組合物,發明專利,美國,US 8,969,406 B2,2015.3.3~2033.3.18 | 2015 . 03 |
獲獎事蹟
獲獎/Award (獲獎名稱,給獎單位,獲獎日期) |
日期 | |
1 | 2022年度國家新創精進獎,財團法人生技醫療科技政策研究中心,2022.12.23 | 2022 . 12 |
2 | 2021年度國家新創獎精進續奬,財團法人生技醫療科技政策研究中心,2021.12.17 | 2021 . 12 |
3 | 第17屆國家新創獎-學研新創獎,財團法人生技醫療科技政策研究中心,2020.9.30 | 2020 . 09 |
4 | 第12屆國家新創獎,科技部,2015.12.24 | 2015 . 12 |